Related Experiment Videos
Lung cancer and peripheral vascular surgery
Canadian Journal of Surgery. Journal Canadien De Chirurgie
|September 1, 1983
Summary
Screening for lung cancer is recommended for patients undergoing peripheral vascular surgery. Early detection through chest X-rays and sputum cytology can improve outcomes for this high-risk group.
Area of Science:
- Oncology
- Pulmonary Medicine
- Vascular Surgery
Background:
- Lung cancer has a low 5-year survival rate despite its preventability through smoking cessation.
- Current screening methods for the general population are not advocated.
- Certain high-risk groups, including those with prior laryngeal, pharyngeal, or lung cancer surgeries, are known.
Purpose of the Study:
- To identify a new high-risk group for lung cancer.
- To evaluate the incidence of lung cancer in patients undergoing peripheral vascular surgery.
- To recommend screening protocols for this patient cohort.
Main Methods:
- Retrospective analysis of 676 patients undergoing peripheral vascular surgery.
- Identification of synchronous (detected during vascular surgery) and metachronous (detected later) lung cancers.
- Review of screening methods including chest roentgenography and sputum cytology.
Main Results:
- Lung cancer was detected in 3.25% of patients undergoing peripheral vascular surgery.
- The study distinguished between synchronous and metachronous lung cancer diagnoses.
- Peripheral vascular disease patients represent a previously unidentified high-risk group for lung cancer.
Conclusions:
- Patients scheduled for peripheral vascular surgery should be screened for lung cancer.
- Recommended screening includes chest roentgenography and sputum cytology.
- Close postoperative follow-up is crucial for early lung cancer detection in this population.